Catalyst Wire Dossier Catalyst Wire Dossier

Neflamapimod

neflamapimod · EIP Pharma Inc
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Neflamapimod, covering 2021-11-02 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of Neflamapimod in Patients With Primary Progressive Aphasia [Phase 2]

See pricing